Literature DB >> 28545419

Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review.

Junliang Yuan1, Shuna Yang1, Shuangkun Wang2, Wei Qin1, Lei Yang1, Wenli Hu3.   

Abstract

BACKGROUND: Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) is a rare clinico-radiological entity characterized by the magnetic resonance imaging (MRI) finding of a reversible lesion in the corpus callosum, sometimes involved the symmetrical white matters. Many cases of child-onset MERS with various causes have been reported. However, adult-onset MERS is relatively rare. The clinical characteristics and pathophysiologiccal mechanisms of adult-onset MERS are not well understood. We reviewed the literature on adult-onset MERS in order to describe the characteristics of MERS in adults and to provide experiences for clinician.
METHODS: We reported a case of adult-onset MERS with acute urinary retension and performed literature search from PubMed and web of science databases to identify other adult-onset MERS reports from Januarary 2004 to March 2016. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline was followed on selection process. And then we summarized the clinico-radiological features of adult-onset MERS.
RESULTS: Twenty-nine adult-onset MERS cases were reviewed from available literature including the case we have. 86.2% of the cases (25/29) were reported in Asia, especially in Japan. Ages varied between 18 and 59 years old with a 12:17 female-to-male ratio. The major cause was infection by virus or bacteria. Fever and headache were the most common clinical manifestation, and acute urinary retention was observed in 6 patients. All patients recovered completely within a month.
CONCLUSION: Adult-onset MERS is an entity with a broad clinico-radiological spectrum because of the various diseases and conditions. There are similar characteristics between MERS in adults and children, also some differences.

Entities:  

Keywords:  Adult-onset MERS; Corpus callosum; Encephalitis; Encephalopathy; Mild encephalitis/encephalopathy with reversible splenial lesion; Reversible plenial lesion

Mesh:

Year:  2017        PMID: 28545419      PMCID: PMC5445341          DOI: 10.1186/s12883-017-0875-5

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


Background

Tada et al. first identified the concept of mild encephalitis/encephalopathy with reversible splenial lesion (MERS) as a rare clinico-radiological syndrome in 2004 [1, 2]. In general, patients with MERS presented with mild central nervous system symptoms such as consciousness disturbance, seizures and headache and recovered completely within a month [1, 3]. MERS is divided into two types according to the lesion location. MERS type I, the typical form, most involves a singular lesion in the midline of the splenium of the corpus callosum (SCC), while MERS type II most commonly presents lesions in the symmetrical cerebral white matter or the anterior aspect of the corpus callosum with similar signal manifestations [4, 5]. The typical magnetic resonance imaging (MRI) features are transient high-signal-intensity on T2-weighted images (T2WI), fluid-attenuated inversion recovery images (FLAIR), and diffusion-weighted images (DWI), decreased apparent diffusion coefficient (ADC) value of the lesion on ADC maps, and hyper-isointense signals on T1-weighted imaging (T1WI) sequences without contrast enhancement [1, 4, 6]. Previous studies have identified that MERS can be triggered by infection including influenza virus [7], rotavirus [8], mumps virus [9], Mycoplasma pneumoniae [10] or Legionella pneumophila [11]. In addition to infection, MERS has also been reported to be associated with the administration of antiepileptic drugs [12-14]. Many child-onset MERS cases have been reported, most in Asia, especially Japan [1, 15]. However, adult-onset MERS is relatively rare. Here we reported a case of adult-onset MERS with acute urinary retention. It has been speculated that the characteristics of MERS in adults are different from that in children. So we utilized this opportunity to review the literature on adult-onset MERS in order to describe the clinico-radiological features and establish a clinical position of the disease.

Methods

Case presentation

A previously healthy 37-year-old man was admitted to our hospital due to a 9-day history of headache and vomiting. Ten days prior to admission, he suddenly developed a fever of 40 °C, diarrhea and headache. After taking oral antipyretics, he still had a fever of 38–39 °C. Three days before admission, his body temperature returned to normal. Two days before admission, he suffered acute urinary retention and was treated by temporary transurethral catheterization at another hospital. One day before admission, he came to our hospital for acute urinary retention and the catheter was kept. Neurological examination revealed nuchal rigidity positive. Chemistry panel and urine analysis showed no abnormalities except for an elevated blood white cell counts (10.99 × 109/L), C-reactive protein level (9.41 mg/L) and decreased serum sodium (131.8mml/L). Routine immunological screening and tumor markers were negative. Lumbar puncture showed an elevated cerebrospinal fluid (CSF) pressure of 190mmH2O. CSF examination demonstrated an increase in white blood cells (97/ul) and protein content (124 mg/dl). The CSF etiological examination was negative. Oligoclonal bands, IgG index and myelin basic protein were within the normal ranges in CSF. Paraneoplastic antibodies were negative. Cranial MRI scans taken on the day after admission showed abnormal signals in SCC, which was hyperintense on T2WI and DWI imaging, decreased on ADC, isointense on T1WI with no contrast enhancement (Fig. 1). The plain and enhancement spinal cord MRI showed no obvious abnormalities. He received intracranial pressure reduction, antiviral, anti-inflammatory and experimental anti-tuberculosis. His urinary retention and fever resolved within 10 days. The follow-up MRI scan taken 14 days after the initial examination showed previous lesion disappeared (Fig. 2). He was discharged home without neurological complications. The final diagnosis was MERS with acute urinary retention.
Fig. 1

Initial cranial MRI of the patient. The lesion in the midline of SCC was hyperintensity on DWI (a) and T2WI (c), decreased ADC value (b), isointense signals on T1WI (d), and no contrast enhancement (e)

Fig. 2

Follow up cranial MRI. The follow up cranial MRI showed no lesion on any sequence (a: DWI, b: ADC, c: T2WI)

Initial cranial MRI of the patient. The lesion in the midline of SCC was hyperintensity on DWI (a) and T2WI (c), decreased ADC value (b), isointense signals on T1WI (d), and no contrast enhancement (e) Follow up cranial MRI. The follow up cranial MRI showed no lesion on any sequence (a: DWI, b: ADC, c: T2WI)

Literature search and selection

To better understand the characteristics of adult-onset MERS, we performed a literature search to identify other reports (reviews, case reports or case series) from Januarary 2004 to March 2016, using the PubMed and web of science databases with the following terms, ‘mild encephalitis/encephalopathy with reversible splenial lesion’/‘MERS’/‘reversible splenial lesion’. All pertinent English language articles were retrieved. A hand-search by reviewing the reference sections of the retrieved articles was also performed. The non-English language articles, child-onset MERS reports and not getting full-text articles were excluded. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline on selection process.

Data extraction

Two investigators collected data from the selected articles. The following information were extracted: last name of the first author, country where the study was performed, the reported patient’s age, gender, CNS symptoms, neurological examination, etiology, auxiliary examination, therapy and outcome.

Results of literature review

A total of 435 articles between Januarary 2004 and March 2016 were identified by preliminary electronic literature search and hand search. The selection process was presented in Fig. 3. The characteristics of the included cases were presented in Table 1 and Table 2.
Fig. 3

Flow diagram of studies selection process

Table 1

Information of 29 adult-onset MERS cases

Reported by, location, referenceCase no.Sex, age (years)symptomsisNeurological examinationEtiology
Beijing Chaoyang Hospital, China1M, 37Fever, UTcervical rigidity (+)NQ
Tada et al. [1] Japan2F, 59Fever, vertigo, lethargyNSNQ
3F, 18Fever, seizure, deliriumNSNQ
4M, 19Fever, cough, delirium, seizureNSNQ
5F, 25Fever, vesicular, headache, drowsiness, nauseaNSVZV
6M, 22Fever, hallucination, deliriumNSNQ
Jun-ichi et al. [22] Japan7M, 31Headache, fever, drowsiness, disorientation, memory disturbancedrowsiness, disorientation, memory disturbanceNQ
Jeong-Seon et al. [6] Korea8M, 59Dysarthria, drowsiness,feverNormalNQ
Nida Tascilar et al. [27] Turkey9F, 26Fever, headache, phonophobia, photophobia, dizziness, UTNeck stiffness (+), positive Kernig’s sign, right truncal and gait ataxiaNQ
Makiko et al. [28] Japan10F, 23Fever, headache, UTUnsteady gait, patellar tendon reflexes, plantar reflexes, abdominal wall reflexes diminishedNQ
Henning Vollmann et al. [29] Germany11M, 42Fever, vomit, headacheMild ataxia, disturbance of gaitTick-bites
Dimitri Renard et al. [30] France12M, 43Stuporous stateGCS E4M5V2, mutism, persistent hiccupAnti-Yo rhombenceh- halitis
Shingo Mitraki et al. [31] Japan13M, 29Consciousness disturbanceDrowsy, disorientedpneumonia
Hideki Shibuya et al. [10] Japan14M, 30Fever, consciousness disturbanceGlasgrow coma scale: E4V1M6Mycoplasma- pneumoniae
Balasubramanyam Shankar et al. [32] India15F, 28Fever, vomiting, paresthesiaDrowsy, neck rigidity, up going plantar reflexNQ
Soon Young Ko et al. [33] Korea16M, 30Fever, alaliadysarthraNonfulminant hepatitis A
Makoto Hibino et al. [34] Japan17F, 24Fever, diarrhea, abdominal pain, weakness of right upper extremityRight-side hemiparesis, hemianesthesia, Chaddock (+)adenovirus
Yuji Tomizawa et al. [11] Japan18M, 49Fever, gait difficultyWide-based gait, fine postural tremors, mildly exaggerate deep tendon reflexesLegionella pneumophila- serogroup 2
Robert M et al. [35] America19M, 41Fever, headache, delirium, consciousness disturbance, tremor, gait instability, paresthesias, UTSlow thought, mild difficulty finding words, intention tremor of the left arm, dysmetria of lower extremities, broad-based gaitipilimumba
Jing Jing Pan et al. [36] China20F, 18Fever(−)NQ
21M, 26Fever, acute UTNuchal rigidity (+)NQ
22F, 23Fever, headache, disturbance of consciousnessKerning (+)C-section
23M, 21Fever, headache, acute UT, intestinal obstructionKerning (+)NQ
Shuo Zhang et al. [37] China24F, 26Headache, fever, seizure, somnolenceSomnolenceMycoplasm-a
25F, 34Dizziness, fever, somnolenceSomnolenceMumps virus
26M,25Headache, fever, cognitive impairment, behavioral disorders, confusionCognitive impairment, behavioral disorders, confusionHerpes simplex virus
Eylem Degirmenci et al. [38] Turkey27M, 27Headache, apathy, nausea, vomitingBilateral papilledema, mildly altered mental statusNQ
Naila Alakbarvova et al. [39] Turkey28M, 46Headache, vomiting, nausea, diarrea, abdominal pain, generalized tonic-clonic seizureConfusing with time disorientationAmanita phalloides intoxication
Matthias Gawlitza et al. [40] Germany29F, 28disorientatedDisorientated, confusionHemolytic uremic syndrome

M male, F female, UT urinary retention, NS no statement, NQ no required, VZV varicella zoster virus

Table 2

Auxiliary examination and treatment of 29 adult-onset MERS cases

Case no.Initial examinationTreatment
WBC (109/L)CRP (g/L)Serum sodium (mmol/L)CSF WBC (106/L)MRIEEG
110.999.41131.8 (hyponatremia)97SCCNEmannitol, low dose methylprednisolone, ACV, anti-tuberculosis
2NSNSNS500SCCSlow BAACV, antibiotics
3NSNSNS17SCCSlow BA and spikesPB, PSL
4NSNSNSNormalSCCSlow BAACV, PHT, PSL
5NSNSNSNESCCNEACV
6NSNSNSNormalSCCSlow BAACV, antibiotics, PSL
718.817.0NS253Entire CC and peripheral WMNSantibiotics
8normalnormalnormalnormalSCC and frontal WMNSNo specific therapy
9normalnormalnormal408SCCnormalCeftriaxone, ACV, ampicillin, catheterization
10normalnormalnormalnormalSCC, WMNSMethylprednisolone pulse, PSL, catheterization
11NSnormal132 (hyponatremia)33SCCNSCeftriaxone, ACV, symptomatic therapy of headache and fever
12NSnormal133 (hyponatremia)6SCC, frontoparie-tal WM, putamina, thalamiDiffuse slowing waveAntiepileptic treatment, methylprednisolone pulse, immunoglobulin treatment
13elevatedelevatedNSnormalEntire CCNSmethylprednisolone pulse, immunoglobulin treatment
14NSNSNSNSSCCNSLevofloxacin
15NSNSNS60SCC, bilateral WMSlow activity, frontal sharp waveEmpirical corticosteroids and ACV
163.48NS138NSSCCabnormalhemodialysis
17normal12.21normalNESCCNSNo specific therapy
18elevated22.91303SCCNSAntibiotics
19normalnormalnormal128SCCNSoral PSL and methylprednisolone pulse
206.08normal137.090SCCabnormalmethylprednisolone pulse, oral PSL
217.10normal130.2100SCC, insula, caudate nucleusabnormalOral methylprednisolone and PSL
2211.20normal138.612SCCabnormalOral methylprednisolone and PSL
238.20normal126.580SCCabnormalOral PSL
24NSNSNS3SCCOccipital slow wavesMannitol, diazepam, macrolides antibiotics and moxifloxacin
25NSNSNS7SCCOccipital slow wavesInterferon, ribavirin
26NSNSNS112SCCOccipital slow wavesGanciclovir, mannitol, antibiotics
27normalnormalnormal150SCCNSAcetazolamide, antibiotics, oseltamivir
2817.8NQnormalnormalSCCNSRisperidone, clozapine, venlafaxine and diazepam, antipsychotic and intoxication treatment
29NSNSNSNSSCCNSeculizumab

WBC white blood cell, CRP C-reactive protein, CSF cerebrospinal fluid, EEG electroencephalography, NE no examined, NS no statement, BA basic activity, ACV acyclovir, PB Phenobarbital, PSL prednisolone, PHT phenytoin, WM white matters

Flow diagram of studies selection process Information of 29 adult-onset MERS cases M male, F female, UT urinary retention, NS no statement, NQ no required, VZV varicella zoster virus Auxiliary examination and treatment of 29 adult-onset MERS cases WBC white blood cell, CRP C-reactive protein, CSF cerebrospinal fluid, EEG electroencephalography, NE no examined, NS no statement, BA basic activity, ACV acyclovir, PB Phenobarbital, PSL prednisolone, PHT phenytoin, WM white matters Of the 29 adult-onset MERS patients, 11 were from Japan, 8 from China, 3 from Turkey, 2 from Germany, 2 from Korea, 1 from France, 1 from India and 1 from America. From a geographical point of view, 86.2% of the countries were in Asia (25/29), especially in Japan (11/29). The age of onset varied between 18 and 59 years old, with an average of 31. Twelve patients were females (41.38%) with a 12:17 female-to-male ratio. Fifteen patients had identified causes, including 5 virus infections, 3 pneumoniae, and 1 mycoplasma infection. One patient developed MERS due to Amanita phalloides toxication, one because of tick-bites. One patient had emotional and behavioral changes presenting with auditory hallucinations within 10 days after C-section. Fever had preceded or simultaneously presented with neurologic symptoms in 24 patients. Twelve patients complained of headache while having MERS, and disturbance of consciousness was observed in 15 cases. Seizure occurred in 4 cases, and acute urinary retention in 6 patients. 75.9% of the patients (22/29) had an isolated lesion in the splenium of the corpus callosum. Six patients had lesions in both splenium and extracallosal. One patient had lesions in the entire corpus callosum. Lumbar punctures were performed in 23 patients, 15 of which had elevated CSF WBCs. Sixteen patients had their serum sodium reported, 6 of which had decreased levels. EEG was performed in 23 patients, 14 of which were abnormal. The patients were treated with antiviral therapy, antibiotics, corticosteroids, IVIG, intravenous osmotic diuretic and isotonic fluid. Thirteen patients received corticosteroids therapy, 5 of which received a methylprednisolone pulse therapy. No case resulted in neurological sequelae.

Discussion

We reported a previously healthy 37-year-old man who suffered MERS associated with acute urinary retention. A lesion in the SCC resulting in acute urinary retention has rarely been reported. We considered acute disseminated encephalomyelitis (ADEM) being the main differential diagnosis. In comparison with the lesions in MERS which show no contrast enhancement and usually disappear quickly [1], the corpus callosum lesions in ADEM are usually asymmetrical, contrast-enhancing, extend to the white matter and spinal cord [16], and resolve over weeks to months. Our patient’s cranial MRI showed an isolated abnormal signal in the SCC with no contrast enhancement. His spinal cord MRI showed no obvious abnormalities. The follow-up MRI scan revealed normalized findings within two weeks. So the patient was diagnosed as MERS instead of ADEM. At first, a reversible isolated SCC lesion on MRI was diagnosed as MERS [1]. Recent studies suggested additional similar lesions in the cerebral white matter and anterior aspects of the corpus callosum in some encephalitis/encephalopathy patients should also been regarded as MERS (type 2 MERS) [4, 5]. Since the radiologic range of MERS had been expanded, patient no.7, 8, 10, 12, 15, 21 and 29 were included in the literature review. Similar to child-onset MERS, most adult-onset MERS patients were also reported in Asia, including Japan, China and India. Interestingly, the majority cases were reported in recent five years. The phenomenon may be related to ethnics and social factors, as well as lack of diagnostic awareness and criteria before 2011. The common neurological manifestations of MERS in adult were headache and disturbance of consciousness. However, disturbance of consciousness and seizures were the most common neurological symptoms in children [15]. We suspect that it is related to children’s immature central nervous system and blood brain barrier. The pathogenesis of MERS is still unknown. There are several hypotheses, including intramyelinic edema, axonal damage, hyponatemia, and oxidative stress [1, 17, 18]. High signal intensity on DWI and decreased ADC values of white matter have been observed in MERS. The possible explanation for this is intrmyelinic edema resulting from separation of myelin layers [19, 20] and local infiltration of inflammatory cells [1, 3]. In this review, we found that more than half (15/23) cases had elevated white cells in the CSF. A previous small sample study reported that patients with MERS has an elevated IL-6 and IL-10 levels in CSF, however, the sample is not enough for any conclusions to be drawn [17]. ADC may return to normal within a week if the intramyelinic edema or inflammatory infiltrate resolves quickly. Takanashi et al. [21] reported that most patients with MERS had mild hyponatremia with a mean serum sodium level (131.0 ± 4.1 mmol/L) lower than that of the healthy group. Our review revealed that 6/16 MERS patients had hyponatremia upon admission. All these indicate that hyponatremia might be a possible cause of MERS. Taken all together, MERS is a rare syndrome with unclear pathogenesis. None of the existing hypotheses explains why MERS specially involves the site splenium. In any patients presenting with symptoms of encephalitis/encephalopathy who are found to have lesions in the white matter, ADEM should be included in the differentials [1, 4, 22, 23]. ADEM is a post-infectious inflammatory disorder which can present with seizures, focal neurological signs or altered mental status days to weeks after the presumed infections [24]. MRI with contrast shows various enhancements of the lesions in ADEM depending on the stages of the acuity [24]. Other differential diagnoses include posterior reversible encephalopathy syndrome (usually hypertension-related and has subcortical white matter lesion), multiple sclerosis (characteristic relapsing-remitting course), Marchiafava-Bignami disease (often seen in alcoholism), ischemia (usually irreversible and has vascular territory distributions), diffuse axonal injury (head trauma-related), lymphoma (positive contrast enhancement), and extrapontine myelinolysis (happens with electrolyte abnormality) [25]. Even though the evidence of methylprednisolone pulse therapy and IVIG’s efficacy on MERS is still lacking, they are recommended for patients with infectious encephalopathy regardless of the pathogen or clinicl-radiological syndromes [26]. In this review, only five MERS patients were treated with methylprednisolone pulse therapy and two with IVIG treatment. However, all patients without methylprednisolone pulse therapy or IVIG recovered clinically completely, which suggests that those treatments may not be necessary.

Conclusion

In conclusion, we reported a case of an adult-onset MERS with acute urinary retention. Taken together with the previously reported cases, we suggest that MERS in adults is an entity with a broad clinico-radiological spectrum and the prognosis is good. From a geographical point of view, most adult-onset MERS patients were also reported in Asia. The common neurological manifestations were headache and disturbance of consciousness. There are similar characteristics between MERS in adults and children, also some differences.
  37 in total

1.  Mild encephalitis/encephalopathy with a reversible splenial, white matter, putaminal, and thalamic lesions following anti-Yo rhombencephalitis.

Authors:  Dimitri Renard; Guillaume Taieb; Caroline Briere; Christian Bengler; Giovanni Castelnovo
Journal:  Acta Neurol Belg       Date:  2012-05-11       Impact factor: 2.396

Review 2.  Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review.

Authors:  Jing Jing Pan; You-Yan Zhao; Chao Lu; Yu-Hua Hu; Yang Yang
Journal:  Neurol Sci       Date:  2015-07-01       Impact factor: 3.307

3.  Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in a patient presenting with papilledema.

Authors:  Eylem Degirmenci; Taner Degirmenci; Ebru Nevin Cetin; Yılmaz Kıroğlu
Journal:  Acta Neurol Belg       Date:  2014-06-04       Impact factor: 2.396

4.  Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).

Authors:  Rie Miyata; Naoyuki Tanuma; Masaharu Hayashi; Takuji Imamura; Jun-ichi Takanashi; Rieko Nagata; Akihisa Okumura; Hirohumi Kashii; Sunao Tomita; Satoko Kumada; Masaya Kubota
Journal:  Brain Dev       Date:  2011-05-14       Impact factor: 1.961

5.  Ipilimumab-induced encephalopathy with a reversible splenial lesion.

Authors:  Robert M Conry; Joseph C Sullivan; Louis B Nabors
Journal:  Cancer Immunol Res       Date:  2015-04-28       Impact factor: 11.151

6.  Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity?

Authors:  S S Kim; K H Chang; S T Kim; D C Suh; J E Cheon; S W Jeong; M H Han; S K Lee
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

7.  Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis.

Authors:  Anneleen Notebaert; Jef Willems; Line Coucke; Rudy Van Coster; Helene Verhelst
Journal:  Pediatr Neurol       Date:  2013-02       Impact factor: 3.372

8.  A 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection.

Authors:  Tatsuo Fuchigami; Kosei Goto; Maki Hasegawa; Katsuya Saito; Tomoko Kida; Koji Hashimoto; Yukihiko Fujita; Yasuji Inamo; Mitsutaka Kuzuya
Journal:  J Infect Chemother       Date:  2012-05-09       Impact factor: 2.211

Review 9.  Two newly proposed infectious encephalitis/encephalopathy syndromes.

Authors:  Jun-ichi Takanashi
Journal:  Brain Dev       Date:  2009-03-31       Impact factor: 1.961

10.  Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity.

Authors:  Shuo Zhang; Yan Ma; Juan Feng
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more
  19 in total

1.  Anti-MDA5 antibody-positive dermatomyositis with mild encephalopathy with reversible splenial lesion: a possible rare association?

Authors:  Khadija Saghir; Mohammed Chraa; Najib Kissani; Hajar Joulal; Lamiaa Essaadouni; Nissrine Louhab
Journal:  Wien Med Wochenschr       Date:  2022-06-21

2.  Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) following influenza virus infection.

Authors:  Issei Takahashi; Hiroyuki Yano; Mitsuyo Kinjo
Journal:  BMJ Case Rep       Date:  2020-05-11

3.  A Rare Cause of Reversible Splenial Lesion Syndrome: A Case Report with Epilepsy.

Authors:  Bilge Piri Çınar; Handan Akar; Abdullah Taylan
Journal:  Balkan Med J       Date:  2017-09-29       Impact factor: 2.021

4.  Isolated involvement of corpus callosum in metronidazole-induced encephalopathy with concomitant peripheral neuropathy: A case report.

Authors:  Qing Peng; Qian You; Jing Zhang; Shui Liu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

5.  Mild encephalitis/encephalopathy with a reversible splenial lesion due to Plasmodium falciparum malaria: a case report.

Authors:  Momoko Mawatari; Tetsuro Kobayashi; Shinya Yamamoto; Nozomi Takeshita; Kayoko Hayakawa; Satoshi Kutsuna; Norio Ohmagari; Tomoyuki Noguchi; Yasuyuki Kato
Journal:  Trop Med Health       Date:  2018-11-06

6.  Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants.

Authors:  Xue-Lin Li; Jinming Han; Zhong-Rui Yan; Bing-Wei Zhang; Hai-Yang Wang
Journal:  J Neurovirol       Date:  2021-07-05       Impact factor: 2.643

7.  Aphasia and confusion - influenza encephalopathy: atypical presentation of influenza.

Authors:  Reiichiro Obata; Kristina Ernst
Journal:  BMJ Case Rep       Date:  2020-10-10

8.  Segmental Arterial Mediolysis with Preceding Symptoms Resembling Viral Infection Hampers the Differentiation from Polyarteritis Nodosa.

Authors:  Norihiro Nagamura; Hiroshi Higuchi
Journal:  Intern Med       Date:  2019-09-15       Impact factor: 1.271

Review 9.  Reversible lesion in the splenium of the corpus callosum.

Authors:  Syuichi Tetsuka
Journal:  Brain Behav       Date:  2019-10-06       Impact factor: 2.708

10.  Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series.

Authors:  Xinying Zhang; Na Chen; Jiamin Guo; Shuwei Li; Jiaming Xu; Weiwei Zhu; Aihua Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.